In this episode, I welcome Isaac Oppenheim, CEO of Zida, to discuss revolutionary solutions for overactive bladder (OAB). Isaac shares his personal motivation behind developing the Zida control sock, a device utilizing percutaneous tibial nerve stimulation designed to provide an accessible and effective treatment. We delve into the challenges of existing OAB treatments, patient-centered care, and the impactful results of clinical trials showing an 80% success rate in symptom relief. The conversation also explores the integration of neuromodulation, lifestyle changes, and pelvic floor therapy as comprehensive approaches to managing OAB. Emphasizing the importance of accessibility, we discuss the device's design, ease of use, and affordability through various purchasing options, including Medicare. Join us as we explore these innovative solutions aiming for 100% symptom improvement and the future of personalized medicine in treating overactive bladder.
Zida website https://livezida.com/
TimeLine:
00:28 Introduction to Overactive Bladder
00:59 Isaac Oppenheim's Background and Inspiration
02:21 Developing the Zida Control Sock
09:12 Clinical Trials and Success Rates
11:43 User Experience and Practicality
13:46 Innovative Technology in Textiles
16:10 Understanding the Fit and Sizing
16:57 Overactive Bladder: Prescription vs. Over-the-Counter
17:19 The Importance of Doctor-Patient Communication
18:17 Challenges with Overactive Bladder Treatments
20:46 Insurance Coverage and Costs
25:06 How the Zida Control Device Works
27:09 Future Goals and Research
29:04 Conclusion and Final Thoughts
